New Technologies in the Management of Lumbopelvic Pain
- Conditions
- RehabilitationLow Back PainExercise
- Registration Number
- NCT04685837
- Lead Sponsor
- Alexander Achalandabaso
- Brief Summary
Lumbopelvic pain represents one of the leading causes of disability and pain in the world population. It is estimated that 84% of the world's population will suffer from lumbar pelvic pain in their lifetime. This high prevalence causes it to be classified as a public health problem.
Traditional primary care measures have failed to reduce the prevalence, recurrences and costs of this pathology. In the search for treatments focused on reducing public spending, the concept of tele-rehabilitation appears. It is a tool, via telematics, that provides knowledge on rehabilitation and education in neurobiology of pain, demonstrated in cardiovascular and respiratory diseases. It has been suggested that the use of this instrument could help improve the patient's quality of life at the biopsychosocial level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 70
- Age between 18-65 years.
- Non-specific low back pain less than 12 weeks of evolution.
- Knowledge of new information and communication technologies.
- Internet access.
- Inflammatory pathologies of the locomotor system.
- Infectious processes.
- Oncological processes.
- Neurodegenerative diseases.
- Pain with neuropathic characteristics.
- Fractures.
- Lack of fluency in Spanish.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in Quality of Life Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the SF-12 Questionnaire
- Secondary Outcome Measures
Name Time Method Change in Sleep Quality Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Pittsburgh Sleep Quality Index
Change in Pain perception Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Visual Analog Scale (VAS) from 0 to 10
Change in Intramuscular contraction capacity erector muscles Baseline, 2 months (primary timepoint). Using the Ito test.
Change in Intramuscular contraction capacity hip flexor muscles Baseline, 2 months (primary timepoint). Using the Hip flexion test supine position and sitting position
Change in Kinesiophobia Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Tampa Kinesiophobia Scale (TSK-11) form 11 to 44
Change in Disability Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Oswestry Disability Questionnaire
Change in Physical Activity Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Baecke Physical Activity Questionnaire
Change in Catastrophism Baseline, 2 months (primary timepoint), 3 months after intervention commencement. Using the Pain catastrophizing scale from 0 to 56
Change in Intramuscular contraction capacity extensor flexor muscles Baseline, 2 months (primary timepoint). Using the Hip extension test prone position
Change in Lumbar motor control Baseline, 2 months (primary timepoint). Using the knee extended test.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Centro de Fisioterapia Villatoro-Luque
🇪🇸Alcalá De Henares, Spain
Centro de Fisioterapia Villatoro-Luque🇪🇸Alcalá De Henares, Spain